Troubling Times for Ginkgo Bioworks

The shares of the one-time hedge fund favorite continue to plummet.

Scott Eisen/Bloomberg

Scott Eisen/Bloomberg

Gingko Bioworks’ crumbling stock has been especially volatile this week.

On Monday alone the shares dropped more than 7.21 percent, while on Tuesday they rebounded 2.8 percent to close at $2.91. Unfortunately, the stock has been more than halved since February 1 and is down about 80 percent from its all-time high, making it just one of many companies that went public last year but have since collapsed in price.


To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.